Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB,

Malani A, et al. Assessing the burden of COVID-19 in developing

countries: Systematic review, meta-analysis and public

policy implications. BMJ Glob Health. 2022; 7(5):e008477.

[DOI:10.1136/bmjgh-2022-008477] [PMID]

COVID-19 National Preparedness Collaborators. Pandemic

preparedness and COVID-19: An exploratory analysis of infection

and fatality rates, and contextual factors associated

with preparedness in 177 countries, from Jan 1, 2020, to Sept

, 2021. Lancet. 2022; 399(10334):1489-512.[DOI:10.1016/

S0140-6736(22)00172-6] [PMID]

Aghcheli B, Tahamtan A, Razavi Nikoo H, Bazi Z, Kalani

MR, Moradi A. Evaluation of mutations in SARS-CoV-2 N and

S genes on the proteins stability, immunogenicity, and pathogenicity

in Iranian patients from Golestan province. Int J Pediatr.

; 10(8):16486-97. [DOI:10.22038/ijp.2022.64880.4906]

Polatoğlu I, Oncu-Oner T, Dalman I, Ozdogan S. COVID-

in early 2023: Structure, replication mechanism, variants

of SARS-CoV-2, diagnostic tests, and vaccine & drug

development studies. MedComm (2020). 2023; 4(2):e228.

[DOI:10.1002/mco2.228] [PMID]

Pronker MF, Creutznacher R, Drulyte I, Hulswit RJG, Li Z,

van Kuppeveld FJM, et al. Sialoglycan binding triggers spike

opening in a human coronavirus. bioRxiv. Preprint. 2023;

-29. [DOI:10.1101/2023.04.20.536837]

Costello SM, Shoemaker SR, Hobbs HT, Nguyen AW, Hsieh

CL, Maynard JA, et al. The SARS-CoV-2 spike reversibly samples

an open-trimer conformation exposing novel epitopes.

Nat Struct Mol Biol. 2022; 29(3):229-38. [DOI:10.1038/s41594-

-00735-5] [PMID]

Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P,

Stilianakis NI, et al. The evolution of SARS-CoV-2. Nat Rev

Microbiol. 2023; 21(6):361-79. [DOI:10.1038/s41579-023-

-2] [PMID]

Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes

J; COVID-19 Genomics UK Consortium, et al. SARS-CoV-2

variant biology: Immune escape, transmission and fitness.

Nat Rev Microbiol. 2023; 21(3):162-77. [DOI:10.1038/s41579-

-00841-7] [PMID]

Umitaibatin R, Harisna AH, Jauhar MM, Syaifie PH, Arda

AG, Nugroho DW, et al. Immunoinformatics study: Multi-

Epitope based vaccine design from SARS-CoV-2 spike glycoprotein.

Vaccines (Basel). 2023; 11(2):399. [DOI:10.3390/vaccines11020399]

[PMID]

Naz S, Aroosh A, Caner A, Şahar EA, Toz S, Ozbel Y, et al.

Immunoinformatics approach to design a multi-epitope vaccine

against Cutaneous Leishmaniasis. Vaccines (Basel). 2023;

(2):339. [DOI:10.3390/vaccines11020339] [PMID]

Sahu LK, Singh K. Cross-variant proof predictive vaccine

design based on SARS-CoV-2 spike protein using immunoinformatics

approach. Beni Suef Univ J Basic Appl Sci. 2023;

(1):5. [DOI:10.1186/s43088-023-00341-4] [PMID]

Evolution of SARS-CoV-2 Variants: Implications on immune

escape, vaccination, therapeutic and diagnostic strategies.

Viruses. 2023; 15(4):944. [DOI:10.3390/v15040944]

[PMID]

Thakur S, Sasi S, Pillai SG, Nag A, Shukla D, Singhal R,

et al. SARS-CoV-2 mutations and their impact on diagnostics,

therapeutics and vaccines. Front Med (Lausanne). 2022;

:815389. [DOI:10.3389/fmed.2022.815389] [PMID]

Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson

EC, Harrison EM, et al. SARS-CoV-2 variants, spike mutations

and immune escape. Nat Rev Microbiol. 2021; 19(7):409-

[DOI:10.1038/s41579-021-00573-0] [PMID]

Han W, Chen N, Xu X, Sahil A, Zhou J, Li Z, et al. Predicting

the antigenic evolution of SARS-COV-2 with deep learning.

Nat Commun. 2023; 14(1):3478. [DOI:10.1038/s41467-

-39199-6] [PMID]

Polatoğlu I, Oncu-Oner T, Dalman I, Ozdogan S. COVID-

in early 2023: Structure, replication mechanism, variants

of SARS-CoV-2, diagnostic tests, and vaccine & drug

development studies. MedComm (2020). 2023; 4(2):e228.----

[DOI:10.1002/mco2.228] [PMID]

Khamjan NA, Lohani M, Khan MF, Khan S, Algaissi A. Immunoinformatics

strategy to develop a novel universal multiple

epitope-based COVID-19 vaccine. Vaccines (Basel). 2023;

(6):1090. [DOI:10.3390/vaccines11061090] [PMID]

Qin J, Jeon JH, Xu J, Langston LK, Marasini R, Mou S, et

al. Design and preclinical evaluation of a universal SARSCoV-

mRNA vaccine. Front Immunol. 2023; 14:1126392.

[DOI:10.3389/fimmu.2023.1126392] [PMID]

Ojha R, Singh S, Gupta N, Kumar K, Padhi AK, Prajapati

VK. Multi-pathogen based chimeric vaccine to fight against

COVID-19 and concomitant coinfections. Biotechnol Lett.

; 45(7):779-97. [DOI:10.1007/s10529-023-03380-0] [PMID]

Moustafa RI, Faraag AHI, El-Shenawy R, Agwa MM, Elsayed

H. Harnessing immunoinformatics for developing a

multiple-epitope peptide-based vaccination approach against

SARS-CoV-2 spike protein. Saudi J Biol Sci. 2023; 30(6):103661.

[DOI:10.1016/j.sjbs.2023.103661] [PMID]

Islam MA, Shahi S, Marzan AA, Amin MR, Hasan MN,

Hoque MN, et al. Variant-specific deleterious mutations in

the SARS-CoV-2 genome reveal immune responses and potentials

for prophylactic vaccine development. Front Pharmacol.

; 14:1090717. [DOI:10.3389/fphar.2023.1090717]

[PMID]

Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P,

Stilianakis NI, et al. The evolution of SARS-CoV-2. Nat Rev

Microbiol. 2023; 21(6):361-79.---- [DOI:10.1038/s41579-023-

-2] [PMID]

Gili R, Burioni R. SARS-CoV-2 before and after Omicron:

Two different viruses and two different diseases? J Transl

Med. 2023; 21(1):251. [DOI:10.1186/s12967-023-04095-6]

[PMID]

Arduini A, Laprise F, Liang C. SARS-CoV-2 ORF8: A rapidly

evolving immune and viral modulator in COVID-19. Viruses.

; 15(4):871. [DOI:10.3390/v15040871] [PMID]

Alquraan L, Alzoubi KH, Rababa'h SY. Mutations of

SARS-CoV-2 and their impact on disease diagnosis and severity.

Inform Med Unlocked. 2023; 39:101256. [DOI:10.1016/j.

imu.2023.101256] [PMID]

Focosi D, Quiroga R, McConnell S, Johnson MC, Casadevall

A. Convergent evolution in SARS-CoV-2 spike creates a

variant soup from which new COVID-19 waves emerge. Int J

Mol Sci. 2023; 24(3):2264. [DOI:10.3390/ijms24032264] [PMID]

Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary

Genetics Analysis Version 11. Mol Biol Evol. 2021;

(7):3022-7. [DOI:10.1093/molbev/msab120] [PMID]

Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G,

Gumienny R, et al. SWISS-MODEL: Homology modelling of

protein structures and complexes. Nucleic Acids Res. 2018;

(W1):W296-303. [DOI:10.1093/nar/gky427] [PMID]

Laskowski RA, MacArthur MW, Moss DS, Thornton JM.

PROCHECK: A program to check the stereochemical quality

of protein structures. J Appl Crystallogr. 1993; 26:283-91.

[DOI:10.1107/S0021889892009944]

Rodrigues CH, Pires DE, Ascher DB. DynaMut: Predicting

the impact of mutations on protein conformation, flexibility

and stability. Nucleic Acids Res. 2018; 46(W1):W350-5.

[DOI:10.1093/nar/gky300] [PMID]

Fleri W, Paul S, Dhanda SK, Mahajan S, Xu X, Peters B, et

al. The immune epitope database and analysis resource in

epitope discovery and synthetic vaccine design. Front Immunol.

; 8:278. [DOI:10.3389/fimmu.2017.00278] [PMID]

Doytchinova IA, Flower DR. VaxiJen: A server for prediction

of protective antigens, tumour antigens and subunit

vaccines. BMC Bioinformatics. 2007; 8:4. [DOI:10.1186/1471-

-8-4] [PMID]

Hon J, Marusiak M, Martinek T, Kunka A, Zendulka J,

Bednar D, et al. SoluProt: Prediction of soluble protein expression

in Escherichia coli. Bioinformatics. 2021; 37(1):23-8.

[DOI:10.1093/bioinformatics/btaa1102] [PMID]

Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP

v.2--a server for in silico prediction of allergens. J Mol Model.

; 20(6):2278. [DOI:10.1007/s00894-014-2278-5] [PMID]

Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R;

Open Source Drug Discovery Consortium, et al. In silico approach

for predicting toxicity of peptides and proteins. PLoS

One. 2013; 8(9):e73957. [DOI:10.1371/journal.pone.0073957]

[PMID]

COVID-19 Forecasting Team. Past SARS-CoV-2 infection

protection against re-infection: A systematic review and

meta-analysis. Lancet. 2023; 401(10379):833-42. [DOI:10.1016/

S0140-6736(22)02465-5] [PMID]

Tan ST, Kwan AT, Rodríguez-Barraquer I, Singer BJ, Park

HJ, Lewnard JA, et al. Infectiousness of SARS-CoV-2 breakthrough

infections and reinfections during the Omicron

wave. Nat Med. 2023; 29(2):358-65. [DOI:10.1038/s41591-022-

-x] [PMID]

Vicentini M, Venturelli F, Mancuso P, Bisaccia E, Zerbini A,

Massari M, et al. Risk of SARS-CoV-2 reinfection by vaccination

status, predominant variant and time from prior infection:

A cohort study, Reggio Emilia province, Italy, February

to February 2022. Euro Surveill. 2023; 28(13):2200494.

[DOI:10.2807/1560-7917.ES.2023.28.13.2200494] [PMID]

Rouet R, Henry JY, Johansen MD, Sobti M, Balachandran

H, Langley DB, et al. Broadly neutralizing SARS-CoV-2 antibodies

through epitope-based selection from convalescent

patients. Nat Commun. 2023; 14(1):687. [DOI:10.1038/s41467-

-36295-5] [PMID]

Park SW, Dushoff J, Grenfell BT, Weitz JS. Intermediate

levels of asymptomatic transmission can lead to the highest

epidemic fatalities. PNAS Nexus. 2023; 2(4):pgad106.

[DOI:10.1093/pnasnexus/pgad106] [PMID]

Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L,

et al. IgA dominates the early neutralizing antibody response

to SARS-CoV-2. Sci Transl Med. 2021; 13(577):eabd2223.

[DOI:10.1126/scitranslmed.abd2223] [PMID]

Contreras M, Vicente J, Cerón JJ, Martinez Subiela S, Urra

JM, Rodríguez-Del-Río FJ, et al. Antibody isotype epitope

mapping of SARS-CoV-2 Spike RBD protein: Targets for

COVID-19 symptomatology and disease control. Eur J Immunol.

; 53(4):e2250206. [DOI:10.1002/eji.202250206]

[PMID]

Yerukala Sathipati S, Shukla SK, Ho SY. Tracking the amino

acid changes of spike proteins across diverse host species

of severe acute respiratory syndrome coronavirus 2. iScience.

; 25(1):103560. [DOI:10.1016/j.isci.2021.103560] [PMID]

Olukitibi TA, Ao Z, Warner B, Unat R, Kobasa D, Yao X.

Significance of conserved regions in Coronavirus spike protein

for developing a novel vaccine against SARS-CoV-2 infection.

Vaccines (Basel). 2023; 11(3):545. [DOI:10.3390/vaccines11030545]

[PMID]

Yang LQ, Sang P, Tao Y, Fu YX, Zhang KQ, Xie YH, et al.

Protein dynamics and motions in relation to their functions:

Several case studies and the underlying mechanisms. J Bio mol Struct Dyn. 2014; 32(3):372-93. [DOI:10.1080/07391102.2

770372] [PMID]

Barthe M, Hertereau L, Lamghari N, Osman-Ponchet H,

Braud VM. Receptors and cofactors that contribute to SARSCoV-

entry: Can skin be an alternative route of entry? Int J

Mol Sci. 2023; 24(7):6253. [DOI:10.3390/ijms24076253] [PMID]

Zhao Z, Zhou J, Tian M, Huang M, Liu S, Xie Y, et al. Omicron

SARS-CoV-2 mutations stabilize spike up-RBD conformation

and lead to a non-RBM-binding monoclonal antibody

escape. Nat Commun. 2022; 13(1):4958. [DOI:10.1038/s41467-

-32665-7] [PMID]

Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibodydependent

enhancement and SARS-CoV-2 vaccines and

therapies. Nat Microbiol. 2020; 5(10):1185-91. [DOI:10.1038/

s41564-020-00789-5] [PMID]

Dormeshkin D, Katsin M, Stegantseva M, Golenchenko

S, Shapira M, Dubovik S, et al. Design and immunogenicity

of SARS-CoV-2 DNA vaccine encoding RBD-PVXCP fusion

protein. Vaccines (Basel). 2023; 11(6):1014. [DOI:10.3390/vaccines11061014]

[PMID]

Hou XC, Xu HF, Liu Y, Sun P, Ding LW, Yue JJ, et al. A

Vaccine with multiple receptor-binding domain subunit mutations

induces broad-spectrum immune response against

SARS-CoV-2 variants of concern. Vaccines (Basel). 2022;

(10):1653. [DOI:10.3390/vaccines10101653] [PMID]